Direct Rx recalls

2 recalls.

• Lidocaine Ointment USP recall (Direct Rx)
  DrugClass IIReported November 4, 2026 · Subpotent Drug
• DULOXETINE D/R recall (Direct Rx)
  DrugClass IIReported July 1, 2026 · CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit